Toolkit/fluorescence recovery after photobleaching
fluorescence recovery after photobleaching
Also known as: FRAP
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Fluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within the pathological condensate termed the addivosome. In this context, FRAP is intended to detect restoration of mobility, or reliquefaction, during compound screening.
Usefulness & Problems
Why this is useful
This assay is useful as a phenotypic readout for compounds that may reverse a pathological condensate state by restoring liquid-like molecular dynamics. The supplied evidence specifically positions FRAP as a screening endpoint for addivosome-targeting interventions.
Source:
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Problem solved
FRAP is proposed to address the problem of how to measure restoration of molecular mobility within the addivosome during compound screening. The evidence supports its use as a readout of reliquefaction rather than as a validated therapeutic screening platform.
Source:
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Problem links
Need better screening or enrichment leverage
DerivedFluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within a pathological condensate termed the addivosome. In this context, it is intended to report restoration of mobility, or reliquefaction, during compound screening.
Need conditional recombination or state switching
DerivedFluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within a pathological condensate termed the addivosome. In this context, it is intended to report restoration of mobility, or reliquefaction, during compound screening.
Need precise spatiotemporal control with light input
DerivedFluorescence recovery after photobleaching (FRAP) is proposed as a functional assay readout for liquid-like molecular mobility within a pathological condensate termed the addivosome. In this context, it is intended to report restoration of mobility, or reliquefaction, during compound screening.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
fluorescence recovery reporting molecular mobilityfluorescence recovery reporting molecular mobilityphotobleachingphotobleachingTarget processes
recombinationselectionInput: Light
Implementation Constraints
The assay requires light input for photobleaching and fluorescence-based measurement of recovery, consistent with FRAP methodology. Beyond its proposed use as a readout for addivosome reliquefaction in compound screening, the supplied evidence does not specify construct design, instrumentation, cell system, or analysis workflow.
The evidence is limited to a proposal in a single source and does not provide experimental validation, quantitative performance metrics, or benchmarking against alternative assays. No details are supplied on fluorophores, imaging conditions, recovery models, throughput, or biological systems used for implementation.
Validation
Supporting Sources
Ranked Claims
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Proximity labeling is proposed to define state-specific proteomic and post-translational signatures for evaluating the Addivosome model.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Selective clearance of the pathological condensate is proposed using autophagy-tethering chimeras directed at drug-induced signatures.
Approval Evidence
measured by fluorescence recovery after photobleaching
Source:
Diffusion of paracrine factors has been studied using techniques such as fluorescence recovery after photobleaching (FRAP).
Source:
Compounds can be screened for restoration of liquid-like molecular mobility, or reliquefaction, using fluorescence recovery after photobleaching as the readout.
Source:
FCS, FRAP, FDAP, and single-molecule tracking are used to study diffusion of paracrine factors through extracellular space.
Source:
Comparisons
Source-backed strengths
The cited literature explicitly proposes FRAP as a direct functional readout of liquid-like molecular mobility in the addivosome context. Its conceptual strength here is that recovery after photobleaching can report changes in condensate material state during screening.
Compared with droplet microfluidic platform
fluorescence recovery after photobleaching and droplet microfluidic platform address a similar problem space because they share recombination, selection.
Shared frame: same top-level item type; shared target processes: recombination, selection; same primary input modality: light
Compared with FLIPR
fluorescence recovery after photobleaching and FLIPR address a similar problem space because they share recombination, selection.
Shared frame: same top-level item type; shared target processes: recombination, selection; same primary input modality: light
Compared with open-source microplate reader
fluorescence recovery after photobleaching and open-source microplate reader address a similar problem space because they share recombination, selection.
Shared frame: same top-level item type; shared target processes: recombination, selection; same primary input modality: light
Ranked Citations
- 1.